Published in Diabetes Technol Ther on February 08, 2012
[Trial of device that is not approved or cleared by the U.S. FDA] | NCT01148862
Type 1 diabetes. Lancet (2013) 3.45
Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps. Diabetes Technol Ther (2015) 1.54
Challenges and Recent Progress in the Development of a Closed-loop Artificial Pancreas. Annu Rev Control (2012) 1.49
Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study. Diabetes Technol Ther (2015) 1.41
Real-time improvement of continuous glucose monitoring accuracy: the smart sensor concept. Diabetes Care (2012) 1.37
Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. Diabetes Care (2015) 1.32
Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia. Diabetes Technol Ther (2013) 1.26
Safety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose. Diabetes Care (2013) 1.09
The Impact of Accelerometer and Heart Rate Data on Hypoglycemia Mitigation in Type 1 Diabetes. J Diabetes Sci Technol (2014) 1.00
Technology to optimize pediatric diabetes management and outcomes. Curr Diab Rep (2013) 0.96
ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia. J Diabetes Sci Technol (2013) 0.95
Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study. Diabetes Technol Ther (2013) 0.94
Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments. Endocrinol Metab Clin North Am (2012) 0.93
A review of artificial pancreas technologies with an emphasis on bi-hormonal therapy. Diabetes Obes Metab (2013) 0.92
Susceptibility of interstitial continuous glucose monitor performance to sleeping position. J Diabetes Sci Technol (2013) 0.90
The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetes. J Diabetes Sci Technol (2014) 0.88
Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev (2015) 0.88
Continuous glucose monitoring: evidence and consensus statement for clinical use. J Diabetes Sci Technol (2013) 0.87
The artificial pancreas: is it important to understand how the β cell controls blood glucose? J Diabetes Sci Technol (2013) 0.86
Factors affecting the success of glucagon delivered during an automated closed-loop system in type 1 diabetes. J Diabetes Complications (2014) 0.86
Challenges and Opportunities in the Management of Cardiovascular Risk Factors in Youth With Type 1 Diabetes: Lifestyle and Beyond. Curr Diab Rep (2015) 0.80
Low glucose suspend: ready for prime time? Diabetes Technol Ther (2012) 0.80
The role of continuous glucose monitoring in the care of children with type 1 diabetes. Int J Pediatr Endocrinol (2013) 0.78
Continuous Glucose Monitoring: Impact on Hypoglycemia. J Diabetes Sci Technol (2016) 0.78
Effectiveness of Automated Insulin Management Features of the MiniMed(®) 640G Sensor-Augmented Insulin Pump. Diabetes Technol Ther (2016) 0.78
Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery. J Diabetes Sci Technol (2015) 0.77
Insulin delivery methods: Past, present and future. Int J Pharm Investig (2016) 0.77
The artificial pancreas: evaluating risk of hypoglycaemia following errors that can be expected with prolonged at-home use. Diabet Med (2015) 0.77
5(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, May 3-5, 2012, Dublin, Ireland. Diabetes Technol Ther (2012) 0.76
Continuous Glucose Monitoring Adherence: Lessons From a Clinical Trial to Predict Outpatient Behavior. J Diabetes Sci Technol (2016) 0.76
Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes. J Diabetes Sci Technol (2016) 0.75
6(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, April 25-27, 2013, Riga, Latvia. Diabetes Technol Ther (2013) 0.75
The Future of Glucose Monitoring. Diabetes Technol Ther (2016) 0.75
Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system. J Artif Organs (2016) 0.75
Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med (2010) 8.69
Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med (2013) 6.64
Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther (2008) 3.82
Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements. Diabetes Care (2007) 3.65
Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab (2010) 2.89
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther (2013) 2.85
Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care (2011) 2.83
Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr (2005) 2.83
Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics (2004) 2.65
Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab (2008) 2.52
Detection of a meal using continuous glucose monitoring: implications for an artificial beta-cell. Diabetes Care (2007) 2.30
Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump. J Diabetes Sci Technol (2011) 2.28
Characterization of Arabidopsis ABCG11/WBC11, an ATP binding cassette (ABC) transporter that is required for cuticular lipid secretion. Plant J (2007) 2.19
Randomized trial of infusion set function: steel versus teflon. Diabetes Technol Ther (2013) 2.15
The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes. Diabetes Technol Ther (2008) 2.00
The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care (2006) 1.95
Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol (2002) 1.94
Accuracy of the SEVEN continuous glucose monitoring system: comparison with frequently sampled venous glucose measurements. J Diabetes Sci Technol (2009) 1.93
Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther (2006) 1.89
The missing element of telemedicine for diabetes: decision support software. J Diabetes Sci Technol (2009) 1.83
Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. Diabetes Technol Ther (2005) 1.75
Influence of race, ethnicity, and culture on childhood obesity: implications for prevention and treatment: a consensus statement of Shaping America's Health and the Obesity Society. Diabetes Care (2008) 1.74
Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. Diabetes Technol Ther (2005) 1.70
Time synching or time sinking? Diabetes Technol Ther (2005) 1.70
Real-Time hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas. Diabetes Care (2010) 1.66
The need for separate performance goals for glucose sensors in the hypoglycemic, normoglycemic, and hyperglycemic ranges. Diabetes Care (2004) 1.55
Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps. Diabetes Technol Ther (2015) 1.54
Using telemedicine to improve outcomes in diabetes--an emerging technology. J Diabetes Sci Technol (2009) 1.52
Blood glucose meter market: this world is undergoing drastic changes. J Diabetes Sci Technol (2013) 1.51
Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr (2004) 1.50
Assisted monitoring of blood glucose: special safety needs for a new paradigm in testing glucose. J Diabetes Sci Technol (2010) 1.48
Risk factors for type 2 diabetes in a sixth- grade multiracial cohort: the HEALTHY study. Diabetes Care (2009) 1.44
A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care (2005) 1.43
Technical aspects of the Parkes error grid. J Diabetes Sci Technol (2013) 1.41
Second insulin pump safety meeting: summary report. J Diabetes Sci Technol (2010) 1.40
Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm. J Diabetes Sci Technol (2012) 1.38
Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor. Diabetes Technol Ther (2014) 1.36
A review of the security of insulin pump infusion systems. J Diabetes Sci Technol (2011) 1.34
Accuracy of the Enlite 6-day glucose sensor with guardian and Veo calibration algorithms. Diabetes Technol Ther (2011) 1.34
Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatr Diabetes (2011) 1.32
Regulatory controversies surround blood glucose monitoring devices. J Diabetes Sci Technol (2010) 1.32
Influence of race, ethnicity, and culture on childhood obesity: implications for prevention and treatment. Obesity (Silver Spring) (2008) 1.29
In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop. Diabetes Technol Ther (2009) 1.24
Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen. Diabetes Technol Ther (2010) 1.22
Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes. Curr Med Res Opin (2010) 1.20
In silico preclinical trials: methodology and engineering guide to closed-loop control in type 1 diabetes mellitus. J Diabetes Sci Technol (2009) 1.19
Vitamin D deficiency in the San Francisco Bay Area. J Pediatr Endocrinol Metab (2006) 1.19
Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset. Diabetes Care (2011) 1.17
Frequency of morning ketosis after overnight insulin suspension using an automated nocturnal predictive low glucose suspend system. Diabetes Care (2014) 1.17
Insights from a large observational database of continuous glucose monitoring adoption, insulin pump usage and glycemic control: the CareLink™ database. Pediatr Endocrinol Rev (2010) 1.16
New evidence demonstrates that self-monitoring of blood glucose does not improve outcomes in type 2 diabetes-when this practice is not applied properly. J Diabetes Sci Technol (2008) 1.15
Improvement in risk factors for metabolic syndrome and insulin resistance in overweight youth who are treated with lifestyle intervention. Pediatrics (2006) 1.14
The need for clinical accuracy guidelines for blood glucose monitors. J Diabetes Sci Technol (2012) 1.14
The feasibility of detecting neuropsychologic and neuroanatomic effects of type 1 diabetes in young children. Diabetes Care (2011) 1.14
A closed-loop artificial pancreas using model predictive control and a sliding meal size estimator. J Diabetes Sci Technol (2009) 1.12
A closed-loop artificial pancreas based on risk management. J Diabetes Sci Technol (2011) 1.12
Diabetes and telemedicine: is the technology sound, effective, cost-effective, and practical? Diabetes Care (2003) 1.11
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT. Endocr Pract (2016) 1.09
The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise. Diabetes Technol Ther (2014) 1.08
Ophthalmologic findings in the Cornelia de Lange Syndrome. J AAPOS (2005) 1.08
The Medtronic Minimed Gold continuous glucose monitoring system: an effective means to discover hypo- and hyperglycemia in children under 7 years of age. Diabetes Technol Ther (2007) 1.07
Severe obesity and selected risk factors in a sixth grade multiracial cohort: the HEALTHY study. J Adolesc Health (2010) 1.06
Personalized medicine for diabetes. J Diabetes Sci Technol (2008) 1.05
Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase. Diabetes Care (2011) 1.04
White matter structural differences in young children with type 1 diabetes: a diffusion tensor imaging study. Diabetes Care (2012) 1.03
Use of the Cygnus GlucoWatch biographer at a diabetes camp. Pediatrics (2004) 1.00
SMBG out of control: the need for educating patients about control solution. Diabetes Educ (2013) 0.99
Designing an artificial pancreas system to be compatible with other medical devices. J Diabetes Sci Technol (2008) 0.99
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. Diabetes Technol Ther (2014) 0.99
A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump. J Pediatr (2007) 0.98
A new test strip technology platform for self-monitoring of blood glucose. J Diabetes Sci Technol (2013) 0.98
The current status of bolus calculator decision-support software. J Diabetes Sci Technol (2012) 0.97
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. J Diabetes Sci Technol (2013) 0.97
ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia. J Diabetes Sci Technol (2013) 0.95
Outcome measures for outpatient hypoglycemia prevention studies. J Diabetes Sci Technol (2011) 0.95
Probabilistic evolving meal detection and estimation of meal total glucose appearance. J Diabetes Sci Technol (2009) 0.94
Technology to treat hyperglycemia in trauma. J Diabetes Sci Technol (2007) 0.94
Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes. Diabetes Technol Ther (2014) 0.93
Labor characteristics and program costs of a successful diabetes disease management program. Am J Manag Care (2006) 0.93
Subcutaneous continuous glucose monitoring in severe burn patients. Crit Care Med (2007) 0.92
Practical considerations in the use of real-time continuous glucose monitoring alerts. J Diabetes Sci Technol (2010) 0.92
The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis. Diabetes Technol Ther (2013) 0.92
Quality Control of Insulins and Biosimilar Insulins: What Do We Know? J Diabetes Sci Technol (2016) 0.91
Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic study. Diabetes Technol Ther (2014) 0.90
Point-of-Care Blood Glucose Meter Accuracy in the Hospital Setting. Diabetes Spectr (2014) 0.90
Remote glucose monitoring in cAMP setting reduces the risk of prolonged nocturnal hypoglycemia. Diabetes Technol Ther (2013) 0.90